Investigation of microrna expression profiles associated with human alcoholic cardiomyopathy

Cardiology (Switzerland)

Volumn 130, Issue 4, 2015, Pages 223-233

  Jing, Ling ^a   Jin, Chengmei ^a   Lu, Ying ^b   Huo, Pingyan ^a   Zhou, Lijun ^a   Wang, Ye ^a   Tian, Ye ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Harbin Red Cross Center Hospital   (China)

Author keywords

Alcoholic cardiomyopathy; Microarray analysis; microRNAs; Target genes

Indexed keywords

INOSITOL PHOSPHATE; MICRORNA; MICRORNA 1285; MICRORNA 138; MICRORNA 4262; MICRORNA 485 5P; MICRORNA 506; MICRORNA 512 3P; MICRORNA 548A 5P; MICRORNA 548C 3P; MICRORNA K12 1; NEUROTROPHIN; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLIC CARDIOMYOPATHY; ARTICLE; BIOINFORMATICS; CELL ADHESION; COLOR ULTRASOUND FLOWMETRY; COMPARATIVE STUDY; CONTROLLED STUDY; GENE ONTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; CASE CONTROL STUDY; CLASSIFICATION; ECHOGRAPHY; GENETICS; MIDDLE AGED;

CARDIOMYOPATHY, ALCOHOLIC; CASE-CONTROL STUDIES; HUMANS; MALE; MICROARRAY ANALYSIS; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 84925456158     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000370028     Document Type: Article

References (32)

1. Iacovoni A, De Maria R, Gavazzi A: Alcoholic cardiomyopathy. J Cardiovasc Med 2010; 11: 884-892.
2. Piano MR: Alcoholic cardiomyopathy incidence, clinical characteristics, and pathophysiology. Chest J 2002; 121: 1638-1650.
3. Skotzko CE, Vrinceanu A, Krueger L, Freudenberger R: Alcohol use and congestive heart failure: incidence, importance, and approaches to improved history taking. Heart Fail Rev 2009; 14: 51-55.
4. Pietrzykowski AZ, Friesen RM, Martin GE, Puig SI, Nowak CL, Wynne PM, Siegelmann HT, Treistman SN: Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron 2008; 59: 274-287.
5. Indolfi C, Curcio A: Stargazing microRNA maps a new miR-21 star for cardiac hypertrophy. J Clin Invest 2014: 1-3.
6. Zhang B, Zhou M, Li C, Zhou J, Li H, Zhu D, Wang Z, Chen A, Zhao Q: MicroRNA-92a inhibition attenuates hypoxia/reoxygenationinduced myocardiocyte apoptosis by targeting Smad7. PloS One 2014; 9:e100298.
7. Wang B-W, Wu G-J, Cheng W-P, Shyu K-G: MicroRNA-208a increases myocardial fibrosis via endoglin in volume overloading heart. PloS One 2014; 9:e84188.
8. Chen J-F, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang D-Z: The role of microRNA-1 and micro RNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2005; 38: 228-233.
9. Takaya T, Ono K, Kawamura T, Takanabe R, Kaichi S, Morimoto T, Wada H, Kita T, Shimatsu A, Hasegawa K: MicroRNA-1 and microRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. Circ J 2009; 73: 1492-1497.
10. Zhao Y, Ransom JF, Li A, Vedantham V, Von Drehle M, Muth AN, Tsuchihashi T, Mcmanus MT, Schwartz RJ, Srivastava D: Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007; 129: 303-317.
11. Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R, Olson EN: MicroRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 2008; 22: 3242-3254.
12. Richardson P, Mckenna R, Bristow M, Maisch B, Mautner B, O'connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I: Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-842.
13. Tibshirani R, Hastie T, Narasimhan B, Chu G: Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002; 99: 6567-6572.
14. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995: 289-300.
15. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genomewide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-14868.
16. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
17. Betel D, Wilson M, Gabow A, Marks DS, Sander C: The microRNA. org resource: targets and expression. Nucleic Acids Res 2008; 36:D149-D153.
18. Gene Ontology Consortium: The gene ontology project in 2008. Nucleic Acids Res 2008; 36:D440-D444.
19. Ogata H, Goto S, Fujibuchi W, Kanehisa M: Computation with the KEGG pathway database. Biosystems 1998; 47: 119-128.
20. Tari L, Baral C, Kim S: Fuzzy c-means clustering with prior biological knowledge. J Biomed Inform 2009; 42: 74-81.
21. Piano MR, Phillips SA: Alcoholic cardiomyopathy: pathophysiologic insights. Cardiovasc Toxicol 2014; 14: 291-308.
22. Piano MR: Alcohol and heart failure. J Card Fail 2002; 8: 239-246.
23. Lazarevic AM, Nakatani S, Neskovic AN, Marinkovic J, Yasumura Y, Stojicic D, Miyatake K, Bojic M, Popovic AD: Early changes in left ventricular function in chronic asymptomatic alcoholics: relation to the duration of heavy drinking. J Am Coll Cardiol 2000; 35: 1599-1606.
24. Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau JM, Mont L, Rubin E: The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 1989; 320: 409-415.
25. Kryzhanovsky S, Kolik L, Tsorin I, Ionova E, Stolyaruk V, Vititnova M, Nadorova A, Seredenin S: On the potential use of echocardiography for assessing the formation of alcoholic cardiomyopathy. Hum Physiol 2014; 40: 105-110.
26. Hiltunen JO, Laurikainen A, Vakeva A, Meri S, Saarma M: Nerve growth factor and brainderived neurotrophic factor mRNAs are regulated in distinct cell populations of rat heart after ischaemia and reperfusion. J Pathol 2001; 194: 247-253.
27. Ganigara M, Prabhu A, Kumar RS: LEOPARD syndrome in an infant with severe hypertrophic cardiomyopathy and PTPN11 mutation. Ann Pediatr Cardiol 2011; 4: 74.
28. Toko H, Takahashi H, Kayama Y, Oka T, Minamino T, Okada S, Morimoto S, Zhan D-Y, Terasaki F, Anderson ME: Ca2+/calmodulin-dependent kinase IIdelta causes heart failure by accumulation of p53 in dilated cardiomyopathy. Circulation 2010; 122: 891-899.
29. Mocanu M, Yellon D: PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury? Br J Pharmacol 2007; 150: 833-838.
30. Morton SU, Scherz PJ, Cordes KR, Ivey KN, Stainier DY, Srivastava D: microRNA-138 modulates cardiac patterning during embryonic development. Proc Natl Acad Sci USA 2008; 105: 17830-17835.
31. Jiang L, Liu X, Kolokythas A, Yu J, Wang A, Heidbreder CE, Shi F, Zhou X: Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer 2010; 127: 505-512.
32. Peters SL, Michel MC: The RhoA/Rho kinase pathway in the myocardium. Cardiovasc Res 2007; 75: 3-4.